MedTrace Logo

Sodium Hypoclorite as an Antibacterial Agent Prior to Pulpotomies

NCT04270318 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2020-02-17

No results posted yet for this study

Summary

Aim: The aim of this study was to report the 24-Month radiographical and histological outcome on these previously reported calcium hydroxide (CH) and mineral trioxide aggregate (MTA) pulpotomies using of five percent sodium hypochlorite (NaOCl) as an antibacterial agent to clean the chamber prior to application of the pulpotomy agent.

Materials and Methods: 128 primary molars were randomly divided into two main groups according to pulpotomy material (CH/MTA) and into two sub-groups according to selected the antibacterial agent (NaOCl/physiologic saline) used in the pulpotomy procedure. After these procedures, teeth were followed radiographically for 24 months. Thirty-four successfully treated teeth whose successors roots had completed formation of at least two-thirds of their lengths were extracted for histological evaluation. Fisher's-exact test, Pearson's-chi-square test and MannWhitneyU test with Bonferroni correction were used for statistical analysis.

Conditions

  • Pulpotomy
  • Primary Teeth

Interventions

OTHER

CH Pulpotomy, physiologic saline

Pulp chamber was cleansed with physiologic saline for 30 s.

OTHER

CH pulpotomy, NaOCl

Pulp chamber was cleansed with 5 % NaOCl for 30 s.

OTHER

MTA Pulpotomy, physiologic saline

Pulp chamber was cleansed with physiologic saline for 30 s.

OTHER

MTA pulpotomy, NaOCl

Pulp chamber was cleansed with 5 % NaOCl for 30 s.

Sponsors & Collaborators

  • Izmir Katip Celebi University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-07-31
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04270318 on ClinicalTrials.gov